Nicotine metabolism and CYP2A6 allele frequencies in Koreans

被引:80
|
作者
Kwon, JT
Nakajima, M
Chai, S
Yom, YK
Kim, HK
Yamazaki, H
Sohn, DR
Yamamoto, T
Kuroiwa, Y
Yokoi, T
机构
[1] Kanazawa Univ, Fac Pharmaceut Sci, Div Drug Metab, Kanazawa, Ishikawa 9200934, Japan
[2] Soonchunhyang Univ, Dept Clin Pharmacol, Coll Med, Chonan, South Korea
[3] Showa Univ, Sch Pharmaceut Sci, Dept Clin Pharm, Tokyo 142, Japan
来源
PHARMACOGENETICS | 2001年 / 11卷 / 04期
关键词
genetic polymorphism; nicotine gum; cotinine formation; interindividual variation;
D O I
10.1097/00008571-200106000-00006
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
CYP2A6 is a major catalyst of nicotine metabolism to cotinine, Previously, we demonstrated that the interindividual difference in nicotine metabolism is related to a genetic polymorphism of the CYP2A6 gene in Japanese. To clarify the ethnic differences in nicotine metabolism and frequencies of CYP2A6 alleles, we studied nicotine metabolism and the CYP2A6 genotype in 209 Koreans. The cotinine/nicotine ratio of the plasma concentration 2 h after chewing one piece of nicotine gum was calculated as an index of nicotine metabolism. The genotypes of CYP2A6 gene (CYP2A6*1A, CYP2A6*1B, CYP2A6*2, CYS2A6*3, CYP2A6*4 and CYP2A6*5) were determined by polymerase chain reaction (PCR)-restriction fragment length polymorphism or allele specific(AS)-PCR. There were ethnic differences in the allele frequencies of CYP2A6*1A, CYP2A6*2B, CYP2A6*4 and CYP2A6*5 between Koreans (45.7%, 42.8%, 11.0% and 0.5%, respectively) and Japanese (42.4%, 37.5%, 20.1% and 0%, respectively, our previous data). Similar to the Japanese, no CYP2A6*2 and CYP2A6*3 alleles were found in Koreans, The homozygotes of the CYP2A6*4 allele (four subjects) were completely deficient in cotinine formation, being consistent with the data among Japanese. The heterozygotes of CYP2A6*4 tended to possess a lower metabolic ratio (CYP2A6*1A/CYP2A6*4, 4.79 +/-3.17; CYP2A6*1B/CYP2A6*4, 7.43 +/- 4.97) than that in subjects without the allele (CYP2A6*1A/CYP2A6*1A, 7.42 +/- 6.56; CYP2A6*1A/CYP2A6*1B, 9.85 +/- 16.12; CYP2A6*1B/CYP2A6*1B, 11.33 +/- 9.33). The subjects who possess the CYP2A6*1B allele appeared to show higher capabilities of cotinine formation. It was confirmed that the interindividual difference in nicotine metabolism was closely related to the genetic polymorphism of CYP2A6, The probit plot of the metabolic ratios in Koreans (8.73 +/- 11.88) was shifted to a higher ratio than that in the Japanese (3.78 +/- 3.09), In each genotype group, the Korean subjects revealed significantly higher metabolic ratios than the Japanese subjects, The ethnic difference in cotinine formation might be due to environmental and/or diet factors as well as genetic factors. Pharmacogenetics 11:317-323 (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:317 / 323
页数:7
相关论文
共 50 条
  • [1] The role of CYP2A6*2 in nicotine metabolism
    Riexinger, A
    Collins, S
    Gaertner, I
    Farger, G
    Batra, A
    [J]. NICOTINE & TOBACCO RESEARCH, 2005, 7 (04) : 653 - 653
  • [2] CYP2A6 polymorphism and nicotine metabolism.
    Benowitz, NL
    Tyndale, R
    Jacob, P
    Swan, GE
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P41 - P41
  • [3] CYP2A6 gene polymorphisms impact to nicotine metabolism
    Muliaty, Dewi
    Yusuf, Irawan
    Setiabudy, Rianto
    Wanandi, Septelia I.
    [J]. MEDICAL JOURNAL OF INDONESIA, 2010, 19 (01) : 46 - 51
  • [4] CYP2A6 genotype and the metabolism and disposition kinetics of nicotine
    Benowitz, Neal L.
    Swan, Gary E.
    Jacob, Peyton, III
    Lessov-Schlaggar, Christina N.
    Tyndale, Rachel F.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 80 (05) : 457 - 467
  • [5] Identification of novel CYP2A6*1B variants:: The CYP2A6*1B allele is associated with faster in vivo nicotine metabolism
    Mwenifumbo, J. C.
    Lessov-Schlaggar, C. N.
    Zhou, Q.
    Kranow, R. E.
    Swan, G. E.
    Benowitz, N. L.
    Tyndale, R. F.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (01) : 115 - 121
  • [6] Inactivation of CYP2A6 and CYP2A13 during nicotine metabolism
    von Weymarn, LB
    Brown, KM
    Murphy, SE
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (01): : 295 - 303
  • [7] Association Between Nicotine Metabolism and CYP2A6*1 and CYP2A6*4 Genotypes in an Iranian Population
    Heravi, Reza Entezari
    Ramezani, Mohammad
    Behravan, Javad
    [J]. DNA AND CELL BIOLOGY, 2010, 29 (07) : 369 - 373
  • [8] Effects of whole deletion of CYP2A6 on nicotine metabolism in humans
    Zhang, X
    Ameno, K
    Ameno, S
    Kinoshita, H
    Kubota, T
    Kumihashi, M
    Mostofa, J
    Iwahashi, K
    Ijiri, I
    [J]. DRUG AND CHEMICAL TOXICOLOGY, 2002, 25 (02) : 203 - 213
  • [9] Grapefruit juice inhibits CYP2A6 and nicotine metabolism.
    Hukkanen, J
    Benowitz, NL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P75 - P75
  • [10] Characterization of the novel CYP2A6*21 allele using in vivo nicotine kinetics
    Nael Al Koudsi
    Jill C. Mwenifumbo
    Edward M. Sellers
    Neal L. Benowitz
    Gary E. Swan
    Rachel F. Tyndale
    [J]. European Journal of Clinical Pharmacology, 2006, 62 : 481 - 484